ARTICLE | Financial News
Vidac raises $9M series A round
July 1, 2016 1:06 AM UTC
Vidac Pharma (Jerusalem, Israel) raised $9 million in a series A financing led by new investor Israel Biotech Fund. Existing investors including Mivtach Shamir Holdings also participated.
The company's VDA-1102 ointment is in a Phase II trial to treat actinic keratosis. The candidate is a selective modulator of voltage-dependent anion channel 1 ( VDAC1) and hexokinase 2 (HK2). ...